In patients undergoing angioplasty for femoropopliteal disease, use of a paclitaxel-eluting rather than an uncoated balloon can reduce late lumen loss and restenosis at 6 months and lessen the need ...
Randomized Controlled Trial Results Presented At EuroPCR Demonstrate Advantages Over Uncoated Angioplasty Balloons and Drug-Eluting Stents PARIS – Adding to the growing body of evidence on a novel ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback